London BioScience Innovation Centre welcomes medical imaging company Singapore-based HistoIndex as 50th client.
London, UK, 06 June 2013 – The London BioScience Innovation Centre (LBIC), London’s premier incubator for life science companies, has signed Singapore-based medical imaging company HistoIndex as its 50th registered client.
LBIC and HistoIndex were introduced by London & Partners as part of an inward investment programme to attract international business to the Capital. HistoIndex was attracted to London because of its diverse talent pool and its reputation as Europe's leading commercial centre.
Since its doors opened in 2001, LBIC has supported over 100 life science companies through the provision of high-spec laboratory, office, conference and hot-desking space for biotech start-ups and others in the sector.
HistoIndex joins a network of companies that have access to LBIC’s facilities and expertise to help it develop its business and promote its work. By establishing a London base, HistoIndex will be ideally placed to access the wider European market.
Ken Larkin, LBIC’s CEO, said: “We offer a warm welcome to HistoIndex as our 50th current client. Our facilities and location offer a unique central London base for companies looking to operate in Europe, providing them with a strong foundation for connecting to our industry as part of a thriving community of growing life science companies based at the Centre.”
Gordon Innes, CEO of London & Partners, said: “The fact that HistoIndex has chosen London as its European base is testament to the city’s leading expertise in life sciences. LBIC is spearheading innovation for science and technology in London and it is this convergence of industries and talent that makes London world-leading for life science start-ups. HistoIndex’s commitment to the city recognises London as Europe's science and tech capital, with access to world-class academic centres, hospitals and the largest cluster of life science businesses.”
HE Antony Phillipson, British High Commissioner to Singapore said: “I am delighted that Histolndex has joined LBIC. The UK Government has made a major long-term commitment to support the Life Science sector and this is already opening up new opportunities for business to invest in, and partner with, the UK life science base. The UK’s excellent reputation in research, clinical development, health regulation and health economics, combined with UKTI’s own global connectivity, means the UK is an ideal springboard to other international markets, in Europe and beyond.”
Dr Katarzyna Zarychta, HistoIndex, Vice President for Sales in Europe said: “HistoIndex, a Singaporean company with a proven expertise in Asia and with successfully established offices in Beijing is pleased to open a new office in London as the base for our multiple activities in Europe. We are delighted to be the 50th company in LBIC and to be connected to the life sciences community in the United Kingdom and Europe. We believe that it will offer us remarkable opportunities in extending and growing our activities. HistoIndex is indeed strengthening its presence in Europe as we are planning the imminent opening of a new servicing centre in London.”
Notes for Editors:
About London Bioscience Innovation Centre (http://www.lbic.com)
The London Bioscience Innovation Centre (LBIC) is owned and operated by the Royal Veterinary College (RVC). It is located next to the College and 10 minutes walk from St Pancras International, Eurostar services and the site of the Francis Crick Institute. LBIC offers laboratory, office, hot desking, meeting room and conference facilities to the life sciences industry. For a list of current clients visit http://www.lbic.com/clients
About HistoIndex (http://www.histoindex.com/)
HistoIndex is a technology spin-off company from the Institute of Biotechnology and Nanotechnology (IBN), Agency of Science, Research and Technology (A*Star), Singapore. The company is involved in the development, manufacture and distribution of optical medical imaging equipment for the diagnosis of fibrosis and cancer. Based on revolutionary imaging solutions, its products have opened doors to new medical standards that benefit clinical research, speed up pharmaceutical drug and treatment development and aid clinical diagnostics.
About London & Partners
London & Partners is the official promotional organisation for London. Our company attracts and delivers value to business, students and visitors. London & Partners is a not-for-profit public private partnership, funded by the Mayor of London and a network of commercial partners.
Our remit is to drive leisure and business visitors as well as bidding to secure major events in London, to unlock the city for overseas businesses who want to set up or expand in London and to promote the capital’s world class universities to international students.
Our intention is to work in partnership with organisations in London and across the world to deliver our goal - that London be globally recognised as the best big city on earth.
For more information visit www.londonandpartners.com
For information contact:
Ken Larkin, CEO
London Bioscience Innovation Centre
Tel: +44 (0) 20 7691 2076
Kat Zarychta, Vice President for Sales in Europe
Tel: +65 67744990
For further information about interviews also contact:
Cell: +44(0)7930 317729